Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTreatt Regulatory News (TET)

Share Price Information for Treatt (TET)

Share Price is delayed by 15 minutes
Get Live Data
301.50    -0.50 (-0.17%)
Bid:
302.00
Ask:
302.50
Spread: 0.50 (0.166%)
Market Cap: £177.99m
TET Live PriceLast checked at - London Stock Exchange

Intraday Treatt Share Chart

Share Buyback Programme

10 Apr 2025 07:01

RNS Number : 4134E
Treatt PLC
10 April 2025
 

10 April 2025

Treatt PLC

("Treatt" or the "Company")

Share Buyback Programme

Launch of Share Buyback Programme

Treatt PLC, the manufacturer and supplier of natural ingredients for the beverage, flavour and fragrance industries, is pleased to announce it will commence a share buyback programme (the "Share Buyback Programme"), as referenced in the Company's trading update released today.

Treatt has a strong balance sheet and the Board has considered the Share Buyback Programme as part of the Company's capital allocation framework, whilst also reflecting Treatt's strong cash performance together with the Board's confidence in Treatt's strategy and medium term outlook.

Details of the Share Buyback Programme

The Company has appointed its corporate brokers, Investec Bank plc ("Investec") and Peel Hunt LLP ("Peel Hunt") (together, the "Brokers"), to manage the share buyback programme to repurchase ordinary shares of 2 pence each in the capital of the Company (the "Ordinary Shares") on the Company's behalf from 10 April 2025, for a maximum aggregate consideration of £5 million (the "Buyback Amount"). The Share Buyback Programme will run until the earlier of the Buyback Amount being utilised in the repurchase of Ordinary Shares or the expiry of the 2025 Authority (defined below). Shares repurchased will be held in treasury at the Company's discretion for later reissue or cancellation.

Treatt has given irrevocable and non-discretionary instruction to Investec and Peel Hunt to conduct the Share Buyback Programme on its behalf. The Brokers will act as "riskless" or "matched" principals for the purposes of the Share Buyback Programme, within certain parameters, and will make trading decisions concerning the purchases of Ordinary Shares independently of the Company.

Shares purchased under the Share Buyback Programme will take place in open market transactions and in accordance with the general authority to purchase Ordinary Shares granted to the directors of the Company by its shareholders at the Company's annual general meeting in 2025 (the "2025 Authority"). The maximum number of Ordinary Shares which the Company is authorised to purchase under the 2025 Authority is 6,120,976. In accordance with the 2025 Authority, the maximum price (exclusive of expenses) which may be paid for an Ordinary Share is an amount equal to the higher of (i) 5% above the average of the middle market quotations for an Ordinary Share as derived from the London Stock Exchange Daily Official List on the five business days immediately preceding any Ordinary Shares being purchased and (ii) the higher of the price of the last independent trade and the highest current independent bid for Ordinary Shares on the trading venue where the purchase is carried out. Furthermore, in accordance with the 2025 Authority, the minimum price which may be paid for each Ordinary Share is 2 pence, being the nominal value of an Ordinary Share. The Share Buyback Programme will be conducted in accordance with Article 5(1) of Regulation (EU) 596/2014, as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 (as amended) ("UK MAR") and the provisions of Commission Delegated Regulation (EU) 2016/1052, as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 (as amended), which deal with buyback programmes. The Share Buyback Programme will also be conducted in accordance with Chapter 9 of the Financial Conduct Authority's UK Listing Rules.

Treatt will make further regulatory announcements in respect of repurchases of Ordinary Shares as required.

 

For further information, please contact:

 

Treatt PLC

David Shannon, Chief Executive Officer

Ryan Govender, Chief Financial Officer

 

+44 (0) 1284 702500

Investec Bank Plc - Joint Corporate Broker

+44 (0) 20 7597 5970

Patrick Robb

David Anderson

Shalin Bhamra

 

Peel Hunt LLP - Joint Corporate Broker

+44 (0) 20 7418 8900

George Sellar

Andrew Clark

Finn Nugent

 

MHP - Financial PR

+44 (0) 20 3128 8100

Tim Rowntree

Eleni Menikou

Veronica Farah

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSSSEFUEISEIL
Date   Source Headline
5th Jun 201812:07 pmRNSBlock Listing Six Monthly Return - Replacement
4th Jun 20185:00 pmRNSHolding(s) in Company
4th Jun 201810:42 amRNSBlock Listing Six Monthly Return
1st Jun 201811:30 amRNSTotal Voting Rights
1st Jun 201811:24 amRNSHolding(s) in Company
31st May 20183:50 pmRNSCompletion of disposal
18th May 201811:13 amRNSDirector/PDMR Shareholding
11th May 20184:50 pmRNSDirector/PDMR Shareholding
8th May 20187:19 amRNSHalf-year Report
8th May 20187:15 amRNSDisposal
30th Apr 201812:20 pmRNSTotal Voting Rights and Capital
27th Apr 20184:39 pmRNSHolding(s) in Company
11th Apr 20183:56 pmRNSHolding(s) in Company
6th Apr 20181:31 pmRNSHolding(s) in Company
5th Apr 20187:00 amRNSTrading Update
26th Mar 20184:41 pmRNSDirector/PDMR Shareholding
26th Mar 20184:41 pmRNSDirector/PDMR Shareholding
5th Mar 20183:03 pmRNSDirector/PDMR Shareholding
8th Feb 20183:08 pmRNSHolding(s) in Company
26th Jan 20184:32 pmRNSResult of AGM
25th Jan 20181:47 pmRNSHolding(s) in Company
29th Dec 20177:00 amRNSVoting Rights and Captial
22nd Dec 20179:01 amRNSHolding(s) in Company
21st Dec 20173:23 pmRNSHolding(s) in Company
19th Dec 20173:46 pmRNSDirector/PDMR Shareholding
19th Dec 20173:20 pmRNSHolding(s) in Company
18th Dec 20173:41 pmRNSResult of General Meeting
14th Dec 201710:41 amRNSAnnual Financial Report
6th Dec 20175:04 pmRNSHolding(s) in Company
1st Dec 20174:16 pmRNSBlock Listing Six Monthly Return
1st Dec 20177:00 amRNSTotal Voting Rights
28th Nov 20177:00 amRNSPlacing to raise £21.6 million
28th Nov 20177:00 amRNSFinal Results
10th Nov 201712:34 pmRNSHolding(s) in Company
2nd Oct 20177:00 amRNSTrading Update
29th Sep 20175:14 pmRNSTotal Voting Rights
26th Sep 20178:54 amRNSHolding(s) in Company
21st Sep 201712:23 pmRNSHolding(s) in Company
21st Aug 201711:09 amRNSDirector/PDMR Shareholding
2nd Aug 20175:07 pmRNSTotal Voting Rights
20th Jul 20171:50 pmRNSDirector/PDMR Shareholding
5th Jun 20171:35 pmRNSBlock Listing Six Monthly Return
23rd May 20179:30 amRNSBlock Listing Application
11th May 20174:05 pmRNSHolding(s) in Company
11th May 20174:01 pmRNSDirector/PDMR Shareholding
10th May 20172:53 pmRNSHolding(s) in Company
9th May 20177:00 amRNSHalf-year Report
5th Apr 20174:41 pmRNSHolding(s) in Company
3rd Apr 20175:25 pmRNSDirector/PDMR Shareholding
31st Mar 20173:57 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.